Pack claim
Sildenafil citrate 100 mg
Women's health evidence guide
Lovegra
Lovegra is marketed as sildenafil 100 mg for women. The pink packaging is simple; the evidence is not. Sildenafil may affect physical arousal, but it is not a general treatment for low desire.
Desire and physical arousal are not the same problem
Lovegra is presented as sildenafil citrate 100 mg in packaging aimed at women. Sildenafil changes blood-flow response during sexual stimulation; it does not create desire or resolve the many reasons desire can fall.
Studies of sildenafil in women have produced mixed results. Some research suggests benefit in narrower groups, including certain women with antidepressant-associated sexual dysfunction, while broad trials have not established it as a reliable treatment for low desire. That is why the cause of the difficulty matters more than the colour of the pack.
Lovegra at a glance
Separate the product claim from what has been established for women.
Marketed for
Female sexual arousal or desire concerns
What sildenafil targets
Blood-flow response during stimulation
What it does not target directly
Desire, relationship context or hormonal causes
Evidence
Mixed, with possible benefit in narrower subgroups
Regulatory context
Not FDA-approved for female sexual dysfunction
Lovegra questions
Is Lovegra simply female Viagra?
That nickname hides the key distinction. The product is marketed around the same active ingredient, but evidence for female sexual dysfunction is mixed and sildenafil is not FDA-approved for that use.
Can sildenafil increase desire?
It acts on blood-flow response, not desire itself. A physical arousal response and the wish to have sex are related for some people, but they are not interchangeable.
Who might discuss sildenafil with a specialist?
Research has explored narrower groups, including some women with antidepressant-associated sexual dysfunction. That evidence does not make a 100 mg branded product appropriate for everyone.
Can the pack claim verify what a supplied tablet contains?
No. A label, listing or editorial illustration cannot authenticate a batch or its supply chain.
What should I do in Singapore?
Start with a GP, women's-health clinician or specialist who can assess medication, hormonal, physical and psychological contributors and explain lawful treatment options.
Sources
- FDA: Addyi prescribing information (2025)
Current US indication and risk information for a distinct HSDD treatment.
- HealthHub Singapore: sildenafil
Singapore patient information for sildenafil.
- MOH Singapore: online sale of prescription medicines
Official requirements for online supply of prescription medicines.
Is the concern desire or arousal?
The distinction changes which evidence is relevant. Compare Lovegra's sildenafil claim with flibanserin's narrow HSDD indication.
Content and sources reviewed